Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
08 Jun 2022
Historique:
entrez: 8 6 2022
pubmed: 9 6 2022
medline: 10 6 2022
Statut: epublish

Résumé

As refugees and asylum seekers are at high risk of developing mental disorders, we assessed the effectiveness of Self-Help Plus (SH + ), a psychological intervention developed by the World Health Organization, in reducing the risk of developing any mental disorders at 12-month follow-up in refugees and asylum seekers resettled in Western Europe. Refugees and asylum seekers with psychological distress (General Health Questionnaire-12 ⩾ 3) but without a mental disorder according to the Mini International Neuropsychiatric Interview (M.I.N.I.) were randomised to either SH + or enhanced treatment as usual (ETAU). The frequency of mental disorders at 12 months was measured with the M.I.N.I., while secondary outcomes included self-identified problems, psychological symptoms and other outcomes. Of 459 participants randomly assigned to SH + or ETAU, 246 accepted to be interviewed at 12 months. No difference in the frequency of any mental disorders was found (relative risk [RR] = 0.841; 95% confidence interval [CI] 0.389-1.819; The present study failed to show any long-term preventative effect of SH + in refugees and asylum seekers resettled in Western European countries. Analysis of the PP population and of secondary outcomes provided signals of a potential effect of SH + in the long-term, which would suggest the value of exploring the effects of booster sessions and strategies to increase SH + adherence.

Identifiants

pubmed: 35674122
doi: 10.1017/S2045796022000269
pii: S2045796022000269
pmc: PMC9220789
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e39

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : European Commission
ID : grant agreement No. 779255

Références

BJPsych Open. 2021 Oct 01;7(6):e181
pubmed: 34593084
BMJ Open. 2019 May 14;9(5):e030259
pubmed: 31092670
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
PLoS One. 2017 Feb 2;12(2):e0171030
pubmed: 28151992
World Psychiatry. 2022 Feb;21(1):88-95
pubmed: 35015365
PLoS Med. 2011 May;8(5):e1001034
pubmed: 21629681
Int J Ment Health Syst. 2017 Aug 25;11:51
pubmed: 28855963
Behav Res Ther. 1996 Aug;34(8):669-73
pubmed: 8870294
Psychother Psychosom. 2021;90(6):403-414
pubmed: 34350902
Soc Psychiatry Psychiatr Epidemiol. 1997 Aug;32(6):327-31
pubmed: 9299926
Soc Psychiatry Psychiatr Epidemiol. 2021 Mar;56(3):475-484
pubmed: 32789561
JAMA. 2005 Aug 3;294(5):602-12
pubmed: 16077055
Lancet Psychiatry. 2020 Feb;7(2):162-172
pubmed: 31948935
Acta Psychiatr Scand. 1999 Mar;99(3):171-8
pubmed: 10100911
PLoS Med. 2020 Aug 19;17(8):e1003262
pubmed: 32813696
Clin Psychol Rev. 2018 Jul;63:66-79
pubmed: 29936342
Br J Psychiatry Suppl. 2000;(39):s28-33
pubmed: 10945075
Psychol Med. 2021 May 12;:1-11
pubmed: 33975654
BMC Psychiatry. 2020 Dec 1;20(1):576
pubmed: 33261576
Lancet Glob Health. 2020 Feb;8(2):e254-e263
pubmed: 31981556
World Psychiatry. 2016 Oct;15(3):295-296
pubmed: 27717271
Clin Psychol Rev. 2020 Feb;75:101812
pubmed: 31901882
Acta Psychiatr Scand. 2022 Feb;145(2):132-155
pubmed: 34473342
BJPsych Open. 2021 Oct 15;7(6):e194
pubmed: 34649634
J Immigr Minor Health. 2020 Oct;22(5):1055-1064
pubmed: 32430778
JAMA. 2009 Aug 5;302(5):537-49
pubmed: 19654388
Transcult Psychiatry. 2017 Jun;54(3):304-331
pubmed: 28540768
Eur J Psychotraumatol. 2021 Sep 24;12(1):1975941
pubmed: 34589179
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Epidemiol Psychiatr Sci. 2019 Oct 02;29:e61
pubmed: 31576800
BMJ Glob Health. 2021 Jun;6(6):
pubmed: 34088735
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941

Auteurs

G Turrini (G)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Cochrane Global Mental Health, University of Verona, Verona, Italy.

M Purgato (M)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Cochrane Global Mental Health, University of Verona, Verona, Italy.

F Tedeschi (F)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

C Acartürk (C)

Department of Psychology, Koc University, Istanbul, Turkey.

M Anttila (M)

Faculty of Medicine, Department of Nursing Science, University of Turku, Turku, Finland.

T Au (T)

Department of Mental Health & Substance Use, World Health Organization, Geneva, Switzerland.

K Carswell (K)

Department of Mental Health & Substance Use, World Health Organization, Geneva, Switzerland.

R Churchill (R)

Centre for Review and Dissemination, University of York, York, UK.

P Cuijpers (P)

Department of Clinical, Neuro, and Developmental Psychology, Amsterdam Public Health Institute, and WHO Collaborating Centre for Research and Dissemination of Psychological Interventions, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

F Friedrich (F)

Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.

C Gastaldon (C)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Cochrane Global Mental Health, University of Verona, Verona, Italy.

T Klein (T)

Department of Psychiatry II, Ulm University, Günzburg, Germany.

M Kösters (M)

Department of Psychiatry II, Ulm University, Günzburg, Germany.

T Lantta (T)

Faculty of Medicine, Department of Nursing Science, University of Turku, Turku, Finland.

M Nosè (M)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Cochrane Global Mental Health, University of Verona, Verona, Italy.

G Ostuzzi (G)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Cochrane Global Mental Health, University of Verona, Verona, Italy.

D Papola (D)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Cochrane Global Mental Health, University of Verona, Verona, Italy.

M Popa (M)

Department of Primary Care and Mental Health, University of Liverpool, Liverpool, England.

M Sijbrandij (M)

Department of Clinical, Neuro, and Developmental Psychology, Amsterdam Public Health Institute, and WHO Collaborating Centre for Research and Dissemination of Psychological Interventions, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

L Tarsitani (L)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

L Todini (L)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

E Uygun (E)

Trauma and Disaster, Mental Health, Bilgi University, Istanbul, Turkey.

M Välimäki (M)

Faculty of Medicine, Department of Nursing Science, University of Turku, Turku, Finland.
Xiangya Nursing School, Evidence-based Center, Central South University, Hunan, China.

L Walker (L)

Department of Health Sciences, University of York, York, UK.

J Wancata (J)

Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.

R G White (RG)

School of Psychology, Queen's University Belfast, Belfast, Northern Ireland.

E Zanini (E)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

M van Ommeren (M)

Department of Mental Health & Substance Use, World Health Organization, Geneva, Switzerland.

C Barbui (C)

WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Cochrane Global Mental Health, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH